Ballentine Partners’s Arcutis Biotherapeutics ARQT Stock Holding History

Ballentine Partners’s Portfolio ARQT Stock Details ARQT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$307K	Buy
2023 Q4	–	Sell
2023 Q3	$55.1K	Buy
2023 Q2	$96.3K	Sell
2023 Q1	$112K	Buy
2021 Q3	–	Sell
2021 Q2	$201K	Buy